Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Pulmonary Hypertension (PH): Analysis of PH Key Assessments (Right Heart Catheterization Availability and Baseline NT-proBNP)
J. Behr, S. Nathan, S. Harari, W. Wuyts, K. Kirchgaessler, M. Bengus, F. Gilberg, A. Wells
{"title":"Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Pulmonary Hypertension (PH): Analysis of PH Key Assessments (Right Heart Catheterization Availability and Baseline NT-proBNP)","authors":"J. Behr, S. Nathan, S. Harari, W. Wuyts, K. Kirchgaessler, M. Bengus, F. Gilberg, A. Wells","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1913","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"10 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1913","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}